Document and Entity Information
Document and Entity Information | May 11, 2023 |
Cover [Abstract] | |
Amendment Flag | true |
Entity Central Index Key | 0001762303 |
Document Type | 8-K/A |
Document Period End Date | May 11, 2023 |
Entity Registrant Name | AVITA Medical, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-39059 |
Entity Tax Identification Number | 85-1021707 |
Entity Address, Address Line One | 28159 Avenue Stanford |
Entity Address, Address Line Two | Suite 220 |
Entity Address, City or Town | Valencia |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 91355 |
City Area Code | 661 |
Local Phone Number | 367.9170 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.0001 per share |
Trading Symbol | RCEL |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Amendment Description | On May 12, 2023, AVITA Medical, Inc. (the “Company”) furnished a Current Report on Form 8-K (the “Original Form 8-K”) with a transcript of the Company’s May 11, 2023 conference call discussing the Company’s financial results for its fiscal quarter ended March 31, 2023 as Exhibit 99.2. Exhibit 99.2 to the Original Form 8-K inadvertently included extraneous tabular information from S&P Global Market Intelligence, including financial results and consensus data for the quarter ended March 31, 2023 in Australian Dollars. The Company’s actual results are reported in U.S. Dollars and included $10.6 million in revenue and a net loss of $9.2 million, or $0.37 per share. For further details, please refer to the Company’s Form 10-Q filed with the SEC on May 11, 2023. The information in Item 2.02 of this Current Report on Form 8-K/A is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing. |